NCT05356286 Recording of Intraoperative Spinal Cord Stimulation and Monitoring
| NCT ID | NCT05356286 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | Cervical Stenosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2011-01-21 |
| Primary Completion | 2027-01-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2011-01-21 with a primary completion date of 2027-01-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Opioid overdose suppresses brainstem respiratory circuits, causes apnea, and may result in death. Epidural electrical stimulation (EES) at the cervical spinal cord facilitated motor activity in rodents and humans, and we hypothesized that EES of the cervical spinal cord could antagonize opioid-induced respiratory depression in humans. In this study, we will stimulate the spinal cord during surgery and assess its effects on respiratory function in human patients.
Eligibility Criteria
Inclusion Criteria: * Any patients undergoing brain or spinal cord surgery where spinal neuromonitoring is utilized. Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05356286 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cervical Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05356286 currently recruiting?
Yes, NCT05356286 is actively recruiting participants. Contact the research team at dclu@mednet.ucla.edu for enrollment information.
Where is the NCT05356286 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT05356286 clinical trial?
NCT05356286 is sponsored by University of California, Los Angeles. The trial plans to enroll 150 participants.